In this study, we found that antibody against CD31 is better than antibodies against CD34 and D2-40 in identifying FTC vascular invasion and that FTC prefers to invade the venous rather than the lymphatic vessels. The gene discussed is PECAM1; the disease is thyroid cancer, nonmedullary, 2.